| Year |
Citation |
Score |
| 2024 |
Martins TA, Kaymak D, Tatari N, Gerster F, Hogan S, Ritz MF, Sabatino V, Wieboldt R, Bartoszek EM, McDaid M, Gerber A, Buck A, Beshirova A, Heider A, Shekarian T, ... ... Hutter G, et al. Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker. Nature Communications. 15: 9718. PMID 39521782 DOI: 10.1038/s41467-024-54129-w |
0.316 |
|
| 2024 |
Shekarian T, Ritz MF, Hogan S, Martins TA, Schmassmann P, Gerber A, Roux J, Kaymak D, Durano C, Burger B, Matter M, Hutter G. Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapse. Journal of Neuropathology and Experimental Neurology. PMID 39423857 DOI: 10.1093/jnen/nlae108 |
0.319 |
|
| 2023 |
Schmassmann P, Roux J, Dettling S, Hogan S, Shekarian T, Martins TA, Ritz MF, Herter S, Bacac M, Hutter G. Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. Elife. 12. PMID 38127790 DOI: 10.7554/eLife.92678 |
0.384 |
|
| 2023 |
Schmassmann P, Roux J, Buck A, Tatari N, Hogan S, Wang J, Rodrigues Mantuano N, Wieboldt R, Lee S, Snijder B, Kaymak D, Martins TA, Ritz MF, Shekarian T, McDaid M, ... ... Hutter G, et al. Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. Science Translational Medicine. 15: eadf5302. PMID 37467314 DOI: 10.1126/scitranslmed.adf5302 |
0.308 |
|
| 2022 |
Li A, Muenst S, Hoffman J, Starck L, Sarem M, Fischer A, Hutter G, Shastri VP. Mesenchymal-endothelial nexus in breast cancer spheroids induces vasculogenesis and local invasion in a CAM model. Communications Biology. 5: 1303. PMID 36435836 DOI: 10.1038/s42003-022-04236-5 |
0.301 |
|
| 2022 |
Parmigiani E, Ivanek R, Rolando C, Hafen K, Turchinovich G, Lehmann FM, Gerber A, Brkic S, Frank S, Meyer SC, Wakimoto H, Günel M, Louvi A, Mariani L, Finke D, ... ... Hutter G, et al. Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells. Developmental Cell. PMID 35803280 DOI: 10.1016/j.devcel.2022.06.006 |
0.311 |
|
| 2022 |
Shekarian T, Zinner CP, Bartoszek EM, Duchemin W, Wachnowicz AT, Hogan S, Etter MM, Flammer J, Paganetti C, Martins TA, Schmassmann P, Zanganeh S, Le Goff F, Muraro MG, Ritz MF, ... ... Hutter G, et al. Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery. Science Advances. 8: eabn9440. PMID 35776791 DOI: 10.1126/sciadv.abn9440 |
0.307 |
|
| 2019 |
Shekarian T, Sivado E, Jallas AC, Depil S, Kielbassa J, Janoueix-Lerosey I, Hutter G, Goutagny N, Bergeron C, Viari A, Valsesia-Wittmann S, Caux C, Marabelle A. Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade. Science Translational Medicine. 11. PMID 31645452 DOI: 10.1126/Scitranslmed.Aat5025 |
0.301 |
|
| 2019 |
Hutter G, Theruvath J, Graef CM, Zhang M, Schoen MK, Manz EM, Bennett ML, Olson A, Azad TD, Sinha R, Chan C, Assad Kahn S, Gholamin S, Wilson C, Grant G, et al. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30602457 DOI: 10.1073/Pnas.1721434116 |
0.727 |
|
| 2019 |
Shekarian T, Wachnowicz AT, Flammer J, Paganetti C, Martins T, Muraro M, Schürch CM, Hutter G. ATIM-48 (LTBK-05). MULTIDIMENSIONAL PERSONALIZED RESPONSE ASSESSMENT TO MICROGLIA MODULATORS IN GLIOBLASTOMA BIOREACTORS Neuro-Oncology. 21: vi284-vi284. DOI: 10.1093/Neuonc/Noz219.1198 |
0.442 |
|
| 2019 |
Shekarian T, Wachnowicz A, Flammer J, Paganetti C, Martins T, Muraro M, Schürch C, Hutter G. P12.09 Multidimensional Personalized Response Assessment to Microglia Modulators in Gioblastoma Bioreactors Neuro-Oncology. 21: iii61-iii61. DOI: 10.1093/Neuonc/Noz126.220 |
0.4 |
|
| 2018 |
Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, et al. Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651. PMID 30389946 DOI: 10.1038/S41467-018-07182-1 |
0.691 |
|
| 2018 |
Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, et al. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121. PMID 30297829 DOI: 10.1038/S41467-018-06564-9 |
0.732 |
|
| 2017 |
Zanganeh S, Spitler R, Hutter G, Ho JQ, Pauliah M, Mahmoudi M. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy. Immunotherapy. 9: 819-835. PMID 28877626 DOI: 10.2217/Imt-2017-0041 |
0.364 |
|
| 2017 |
Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, ... ... Hutter G, et al. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9. PMID 28298418 DOI: 10.1126/Scitranslmed.Aaf2968 |
0.764 |
|
| 2017 |
Hutter G, Theruvath J, Graef CM, Weissman I, Mitra SS, Cheshier SH. TMIC-04. A POTENT MICROGLIAL RESPONSE TO BLOCKING THE CD47-SIRPα ANTI-PHAGOCYTIC AXIS OVERCOMES DEFICIENT MACROPHAGE RECRUITMENT DURING ANTI-CD47 IMMUNOTHERAPY AGAINST GLIOBLASTOMA Neuro-Oncology. 19: vi243-vi244. DOI: 10.1093/Neuonc/Nox168.994 |
0.553 |
|
| 2017 |
Hutter G, Theruvath JL, Kahn SA, Graef CM, Schoen MK, Gholamin S, Manz EM, Weissman IL, Mitra SS, Cheshier SH. OS01.4 Induction of differential macrophage and microglial glioblastoma phagocytosis by anti CD47 treatment - implication of tumor subtypes Neuro-Oncology. 19: iii1-iii2. DOI: 10.1093/Neuonc/Nox036.003 |
0.77 |
|
| 2016 |
Hutter G, Sailer M, Azad TD, von Bueren AO, Nollau P, Frank S, Tostado C, Sarvepalli D, Ghosh A, Ritz MF, Boulay JL, Mariani L. Reverse phase protein arrays enable glioblastoma molecular subtyping. Journal of Neuro-Oncology. PMID 27858266 DOI: 10.1007/S11060-016-2316-5 |
0.347 |
|
| 2016 |
Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A, Pajarinen JS, Nejadnik H, Goodman S, Moseley M, Coussens LM, Daldrup-Link HE. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nature Nanotechnology. PMID 27668795 DOI: 10.1038/Nnano.2016.168 |
0.308 |
|
| 2016 |
Sailer MH, Sarvepalli D, Brégère C, Fisch U, Guentchev M, Weller M, Guzman R, Bettler B, Ghosh A, Hutter G. An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery. Journal of Visualized Experiments : Jove. PMID 27583933 DOI: 10.3791/54018 |
0.358 |
|
| 2016 |
Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, et al. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. Plos One. 11: e0153550. PMID 27092773 DOI: 10.1371/Journal.Pone.0153550 |
0.738 |
|
| 2015 |
Hutter G, Hofer S, Tzankov A, Kothbauer KF. Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report. Neurosurgery. PMID 26237342 DOI: 10.1227/Neu.0000000000000925 |
0.396 |
|
| 2015 |
Mitra SS, Feroze AH, Gholamin S, Richard C, Esparza R, Zhang M, Azad TD, Alrfaei B, Kahn SA, Hutter G, Guzman R, Creasey GH, Plant GW, Weissman IL, Edwards MS, et al. Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells. Neurosurgery. PMID 26225855 DOI: 10.1227/Neu.0000000000000918 |
0.705 |
|
| 2015 |
Gholamin S, Kahn SA, Esparza R, Hutter G, Feroze A, Weissman IL, Mitra SS, Cheshier SH. PM-08 * A HUMANIZED CO-TRANSPLANT XENOGRAFT MOUSE MODEL, TO STUDY TOXICITY OF DRUGS TARGETED AGAINST PEDIATRIC BRAIN TUMORS Neuro-Oncology. 17: iii32-iii32. DOI: 10.1093/Neuonc/Nov061.130 |
0.749 |
|
| 2013 |
Sailer MH, Gerber A, Tostado C, Hutter G, Cordier D, Mariani L, Ritz MF. Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling. Journal of Cell Science. 126: 3533-40. PMID 23788430 DOI: 10.1242/Dev.102483 |
0.347 |
|
| 2007 |
Peters R, Hutter G, Aguzzi A, Heikenwaelder M, Renner C, Knuth A. Expansion of Umbilical Cord Blood Hematopoietic Stem Cells for Clinical Use. Blood. 110: 4049-4049. DOI: 10.1182/Blood.V110.11.4049.4049 |
0.373 |
|
| 2006 |
Ingold B, Moschopulos M, Hutter G, Seeger H, Röthlisberger B, Landolt H, Yonekawa Y, Jochum W, Heppner FL. Abdominal seeding of an atypical teratoid/rhabdoid tumor of the pineal gland along a ventriculoperitoneal shunt catheter [2] Acta Neuropathologica. 111: 56-59. PMID 16328512 DOI: 10.1007/S00401-005-1112-7 |
0.381 |
|
| Show low-probability matches. |